Global Trial Seeks Participants for Norovirus Vaccine

An invitation is being extended to individuals aged 60 and above to participate in the testing of a vaccine designed to offer protection against norovirus. This virus, known as a stomach bug, induces symptoms such as vomiting and diarrhoea, spreads readily during the winter season, and has the potential to impact individuals across all age groups. Southmead Hospital, located in Bristol, is actively seeking 70 participants for a worldwide trial of a norovirus vaccine. The North Bristol NHS Trust, which operates the hospital, indicated that “more vulnerable groups” afflicted with norovirus “are more likely to need medical support or higher levels of care.” The vaccine is slated for testing on approximately 25,000 adults, predominantly those over 60, across more than six countries globally over the coming two years as part of this trial. Should it prove effective, researchers anticipate it would decrease the number of vulnerable adults requiring hospitalization in winter, alongside alleviating the financial strain on healthcare systems such as the NHS. The virus has the capacity to affect individuals of any age, potentially leading to the closure of hospital wards and exerting a significant impact on care homes and educational institutions. Concurrently, the UKHSA reported this week that an increase in cases of both influenza and norovirus is now being observed as the winter season approaches. Professor Tim Whittlestone, who serves as the chief medical officer at the trust, stated: “As an innovative forward-thinking trust, we’re proud to be involved in this global trial. It will see if the vaccine that is being studied may be able to protect people 18 years of age or older against the symptoms caused by the norovirus stomach bug.” Sarah Wheatley, the head of infection control and tissue viability at the trust, commented: “The winter vomiting bug, norovirus, spreads very easily from person to person, via close contact with a contaminated person, especially in settings like care homes, hospitals and schools. We are lucky that we benefit from side rooms on our wards, so this does help to limit the risk of infections like norovirus spreading. While most people recover well in a few days, more vulnerable groups are more likely to need medical support or higher levels of care.”